-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Biological, Hemophilia, Bleeding and Clotting, bone marrow, Diseases, GVHD, Therapies, Biological Processes, gene therapy, Immune Disorders, Technology and Procedures, immunotherapy, immune mechanism, transplantation, stem cells, RNA sequencing
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Juliane K. Lohmeyer, MD1*, Toshihito Hirai, MD, PhD1,2*, Mustafa Turkoz, PhD1*, Natalie Koehler, PhD1,3*, Jeanette Baker1*, Stephane Buhler, PhD4*, Jean Villard, MD, PhD4*, Xuhuai Ji, MD, PhD5*, Federico Simonetta, MD, PhD1,6* and Robert S. Negrin, MD7

1Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA
2Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
3University Medical Center Freiburg, Freiburg, Germany
4Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland
5Human Immune Monitoring Center, Stanford University, Stanford, CA
6Division of Hematology and Translational Research Center for Oncohematology, Geneva University Hospitals, Geneva, Switzerland
7Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA

Sharon L. Hyzy, MS1*, Jennifer L Proctor, BS1*, Geoff O Gillard, PhD1*, Katelyn J. Hammond, BS1*, Ganapathy N. Sarma, PhD1*, Asim Saha, PhD2*, Nicholas Clark, PhD1*, Anjali Bhat, MS1*, Tahirih L Lamothe, BS1*, Rahul Palchaudhuri, PhD1*, Bradley R Pearse, PhD1*, Charlotte F McDonagh, PhD1*, Hans-Peter Kiem, MD PhD3, John E Wagner, MD2, Bruce R. Blazar, MD2, Anthony E Boitano, PhD1, Michael P Cooke, PhD1 and John C. Davis Jr., MD, MPH, MS1*

1Magenta Therapeutics, Cambridge, MA
2Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
3Fred Hutchinson Cancer Research Center, Seattle, WA

Quan DM Pham1*, Martin Rodriguez, BSc2, Ritu M Ramamurthy1*, Sunil George, PhD1*, Jorge Figueroa, MD3*, Anthony Atala, M.D.1*, Christopher B Doering, PhD4,5,6, H. Trent Spencer, Ph.D.4,6,7*, Christopher D Porada, PhD1* and M. Graca Almeida-Porada, MD, PhD1

1Fetal Research and Therapy Program, Wake Forest Institute for Regenerative Medicine, Winston Salem, NC
2Fetal Research and Therapy Program, Wake Forest Institute for Regenerative Medicine, Advance, NC
3Center for Research in Obstetrics and Gynecology, Wake Forest School of Medicine, Winston Salem
4Aflac Cancer and Blood Disorders Center, Emory University/Children's Healthcare of Atlanta, Atlanta, GA
5Department of Pediatrics, Emory University, Atlanta, GA
6Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
7Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

Mateusz Adamiak, PhD1*, Arjun Thapa2*, Kamila Bujko, MSc3*, Valentina Pensato4*, Magdalena Kucia, PhD, DSci1,5, Janina Ratajczak, MD, PhD, DSci3 and Mariusz Z Ratajczak, MD, PhD, DSc1

1Department of Regenerative Medicine, Warsaw Medical University, Warsaw, Poland
2Stem Cell Program at JGB Cancer Center, University of Louisville, Louisville, KY
3Stem Cell Institute at JGB CC, University of Louisville, Louisville, KY
4Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “ L. and A. Seràgnoli”, University of Bologna, Bologna, Italy, Bologna, Italy
5Stem Cell Institute, University Of Louisville Brown Cancer Center, Louisville, KY

*signifies non-member of ASH